# Soluble B7-H3 as a Biomarker for Osteosarcoma

> **NCT05942456** · — · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Biomarker
- Progression
- Osteosarcoma
- Surveillance

## Interventions

- **DIAGNOSTIC_TEST:** ELISA: enzyme-linked immunosorbent assay

## Key facts

- **NCT ID:** NCT05942456
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-05
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05942456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05942456, "Soluble B7-H3 as a Biomarker for Osteosarcoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05942456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*